Fuchs, Flávio D.
Scala, Luiz C. N.
Vilela-Martin, José F.
Whelton, Paul K.
Poli-de-Figueiredo, Carlos E.
Pereira E Silva, Ricardo
Gus, Miguel
Bortolotto, Luiz A.
Consolim-Colombo, Fernanda M.
Schlatter, Rosane P.
Cesarino, José E.
Castro, Iran
Figueiredo Neto, José A.
Chaves, Hilton
Steffens, André A.
Alves, João G.
Brandão, Andréa A.
de Sousa, Marcos R.
Jardim, Paulo C.
Moreira, Leila B.
Franco, Roberto S.
Gomes, Marco M.
Afiune Neto, Abrahão
Fuchs, Felipe C.
Sobral Filho, Dario C.
Nóbrega, Antônio C.
Nobre, Fernando
Berwanger, Otávio
Fuchs, Sandra C. http://orcid.org/0000-0001-6351-9588
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial
https://doi.org/10.1007/s00592-020-01611-8
Funding for this research was provided by:
Department of Science and Technology (DECIT), Health Ministry
National Research Council of Science and Technology
Agency for Funding of Studies and Projects (01080606/01)
Hospital de Clínicas de Porto Alegre (GPPG: 08-621)
Article History
Received: 3 August 2020
Accepted: 23 September 2020
First Online: 13 October 2020
Change Date: 1 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00592-021-01689-8
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: The study was approved by the Ethics Committee of the Hospital de Clinicas de Porto Alegre (GPPG 08-621), which is accredited by the Office of Human Research Protections as an Institutional Review Board, and by the ethics committee at each medical center. The PREVER-Treatment trial was conducted in 21 academic medical centers in Brazil, and was approved by the Research Ethics Board of each participant institution.
: Eligible participants were enrolled in the trial and gave written informed consent prior to their inclusion in the study.